Relius Lifesciences Private Limited, a active private limited company, was established on 21 November 2016 in Ahmedabad, Gujarat, India. Engaging in business & it consulting within the support service to organizations sector, it holds CIN: U24299GJ2016PTC094454. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Espee Injectables Private Limited. It upholds a compliant status. Its leadership includes Swapnil Jatinbhai Shah (Director), Anar Swapnil Shah (Director), Roma Vinodbhai Shah (Director). Past directors included Jatinbhai Siddharthbhai Shah, Anar Swapnil Shah, Shimul Subhash Kumar Banerjee. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at S.T. 1101, One 42, B/H. Ashok Vatika, Nr. Jayantilal Park Brts, Ambli Bopal Ro, Ad, Ahmedabad, Gujarat, 380054.
U24299GJ2016PTC094454
094454
21 November 2016
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Relius Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swapnil Jatinbhai Shah | Director | 21 Nov 2016 | Current |
| Anar Swapnil Shah | Director | 30 Jul 2020 | Current |
| Roma Vinodbhai Shah | Director | 21 Nov 2016 | Current |
| Arpit Deepakkumar Shah | Director | 21 Nov 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Mar 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
| Pramod Abcsdd | Director | 13 Feb 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Relius Lifesciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 18.66% increase in profit. The company's net worth observed a substantial decline by a decrease of 51.87%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Relius Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Relius Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Relius Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relius Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Relius Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Relius Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
Progress on Anar Swapnil Shah was appointed as a Director was appointed as a Director on 30 Jul 2020 & has been associated with this company since 5 years 4 months . was documented.
The activity Swapnil Jatinbhai Shah was appointed as a Director was appointed as a Director on 21 Nov 2016 & has been associated with this company since 9 years 7 days . was completed.
Progress on Roma Vinodbhai Shah was appointed as a Director was appointed as a Director on 21 Nov 2016 & has been associated with this company since 9 years 7 days . was documented.
The activity Arpit Deepakkumar Shah was appointed as a Director was appointed as a Director on 21 Nov 2016 & has been associated with this company since 9 years 7 days . was completed.
The CIN of Relius Lifesciences Private Limited is U24299GJ2016PTC094454.
Relius Lifesciences Private Limited is headquartered at S.T. 1101, One 42, B/H. Ashok Vatika, Nr. Jayantilal Park Brts, Ambli Bopal Ro, Ad, Ahmedabad, Gujarat, 380054.
Relius Lifesciences Private Limited was incorporated on 21 November 2016.
The current directors of Relius Lifesciences Private Limited are
The primary industry of Relius Lifesciences Private Limited is Support Service To Organizations.
Relius Lifesciences Private Limited is unlisted.
The authorized capital of Relius Lifesciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Relius Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX